Light Therapy in Parkinson's Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorSecond Affiliated Hospital of Soochow University
About this trial
The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
Eligibility criteria
Qualifiers
According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3.
All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period.
Disqualifiers
Using hypnotic or stimulating drugs.
Using antidepressants, except stable drugs maintained for more than three months;
Visual impairment, such as cataract, glaucoma, blindness, etc;
Cognitive impairment (MMSE < 24);
Trial design
Treatments tested in this trial
- Bright light box
- Dim Light box
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov